Legal documents note that the original labels lacked warnings of severe side effects, from gastrointestinal issues to vision problems
Your prescribing clinician, whether your GP or a specialist within a Tier 3 weight management service, is there to support you
This is the most common reason patients plateau at weeks 4 to 8 without having reached their full potential
If you notice lipohypertrophy (lumpy or thickened skin at injection sites), switching to the oral formulation or rotating sites more carefully may help
Previous studies have described developmental, phenotypic, functional and transcriptomic differences between MZB and FoB 7,8,9,10,11,12,13,14
6 mGIPR-Ab/P1 treatment and CNS GIPR KO result in gene expression profile changes in liver